XML 51 R39.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Benefit (Provision)

The provision for income taxes includes the following components for the years ended December 31, 2024 and 2023 (in thousands):

 

 

 

Year Ended
December 31,

 

 

 

2024

 

 

2023

 

Current:

 

 

 

 

 

 

Federal

 

$

 

 

$

 

State

 

 

 

 

 

 

Total current benefit (provision)

 

$

 

 

$

 

Deferred:

 

 

 

 

 

 

Federal

 

$

8,981

 

 

$

8,178

 

State

 

 

4,198

 

 

 

2,198

 

Change in valuation allowance

 

 

(13,179

)

 

 

(10,376

)

Total deferred benefit (provision)

 

$

 

 

$

 

Total income tax benefit (provision)

 

$

 

 

$

 

Schedule of Effective Income Tax Rate Reconciliation

The benefit (provision) for income taxes differs from the amount computed at federal statutory rates as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

Computed Federal income tax benefit (expense) at the
   statutory rate

 

$

6,908

 

 

 

21.00

%

 

$

7,602

 

 

 

21.00

%

R&D credits

 

 

837

 

 

 

2.54

%

 

 

698

 

 

 

1.93

%

Equity-based expenses

 

 

2,366

 

 

 

7.19

%

 

 

(63

)

 

 

(0.17

)%

State income taxes, net of federal benefit

 

 

3,272

 

 

 

9.95

%

 

 

1,783

 

 

 

4.92

%

State net operating loss carryforward true up

 

 

 

 

 

%

 

 

154

 

 

 

0.42

%

Change in statutory rates

 

 

813

 

 

 

2.47

%

 

 

163

 

 

 

0.45

%

Other

 

 

(1,017

)

 

 

(3.09

)%

 

 

39

 

 

 

0.11

%

Valuation allowance

 

 

(13,179

)

 

 

(40.06

)%

 

 

(10,376

)

 

 

(28.66

)%

Income tax benefit (provision)

 

$

 

 

 

%

 

$

 

 

 

%

Schedule of Deferred Tax Assets and Liabilities

Significant components of the Company’s net deferred income tax assets (liabilities) are as follows (in thousands):

 

 

 

December 31,

 

 

 

2024

 

 

2023

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$

61,615

 

 

$

53,072

 

R&D credits

 

 

4,693

 

 

 

3,856

 

R&E expenses

 

 

8,127

 

 

 

5,219

 

Accruals and reserves

 

 

409

 

 

 

278

 

Equity-based compensation

 

 

3,193

 

 

 

2,440

 

Depreciation and amortization

 

 

5

 

 

 

 

Lease liability

 

 

184

 

 

 

317

 

Other

 

 

7

 

 

 

7

 

Total deferred tax asset before allowance

 

 

78,233

 

 

 

65,189

 

Less: valuation allowance

 

 

(78,058

)

 

 

(64,879

)

Total deferred tax asset

 

 

175

 

 

 

310

 

Deferred tax liabilities:

 

 

 

 

 

 

Right-of-use asset

 

 

(175

)

 

 

(306

)

Depreciation and amortization

 

 

 

 

 

(4

)

Net deferred tax assets

 

$

 

 

$

 

Schedule of Uncertain Tax Positions Roll Forward A reconciliation of the beginning and ending amount of uncertain tax positions (in thousands):

 

 

 

Year Ended
December 31,

 

 

 

2024

 

 

2023

 

Balance at the beginning of the year

 

$

2,570

 

 

$

2,025

 

Gross increases—prior period

 

 

 

 

 

80

 

Gross increases—current period

 

 

559

 

 

 

465

 

Balance at the end of the year

 

$

3,129

 

 

$

2,570